MYLAN 357 (Pentoxifylline 400 mg)

Pill imprint MYLAN 357 has been identified as Pentoxifylline 400 mg.

Pentoxifylline is used in the treatment of intermittent claudication and belongs to the drug class miscellaneous coagulation modifiers. Risk cannot be ruled out during pregnancy. Pentoxifylline 400 mg is not a controlled substance under the Controlled Substance Act (CSA).

Pentoxifylline

Imprint:

MYLAN 357

Strength:

400 mg

Color:

Purple

Size:

16.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Miscellaneous coagulation modifiers

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-0357

Inactive Ingredients:

D&C Red No. 30
FD&C Blue No. 2
FD&C Yellow No. 6
hydroxyethyl cellulose (140 mpa.s at 5%)
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
titanium dioxide
triacetin

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
51079-0889	UDL Laboratories Inc

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.